JPRN-UMIN000047162尚未招募未知
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer - Biomarkers to predict irAEs in patients with NSCLC
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 114
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with active double cancer (simultaneous double cancer and metachronous double cancer with no disease period within 3 years). 2. Patients with ILD complications prior to treatment (Intestinal Lung Abnormality (ILA) is acceptable). 3. Patients with autoimmune disease. 4. Patients taking 10 mg or more of prednisolone. 5. Patients who the principal investigator deems inappropriate for this study.
研究者
相似试验
招募中
不适用
Determining prognostic immune markers in patients with ovarian cancer * a prospective explorative cohort study.Ovarian cancerNL-OMON48676eids Universitair Medisch Centrum300
进行中（未招募）
1 期
prediction of response to therapy in inflammatory bowel diseaseEUCTR2018-002925-47-ESFundación de Investigación Biomédica del Hospital Universitario de La Princesa180
已完成
不适用
Investigation of biomarkers for predicting the response to steroids in patients with COPDCOPDJPRN-UMIN000010711Third Department of Internal Medicine, Wakayama Medical University80
招募中
不适用
Biomarker studies for potentially predicting response to nivolumab in patients with unresectable or recurrent non-small cell lung cancerunresectable or recurrent non-small cell lung cancerJPRN-UMIN000026040Kagoshima University90
已完成
不适用
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyHead and Neck CancerHuman PapillomavirusSquamous Cell CancerOropharyngeal CancerNCT01358097Icahn School of Medicine at Mount Sinai33